FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称VECILMERAN
异名/同义词MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING A CODON-OPTIMISED RECEPTOR BINDING DOMAIN (RBD) OF THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) GLYCOPROTEIN (OMICRON SUB-LINEAGES B.1.1.529.4 AND B.1.1.529.5; ALSO KNOWN AS BA.4 AND BA.5; BASED UPON, GISAID: EPI_ISL_12431317) EXPRESSED AS A FUSION PROTEIN WITH A HUMAN IMMUNOGLOBULIN (IG) .EPSILON.-CHAIN SIGNAL PEPTIDE, FLANKED BY A 5' UNTRANSLATED REGION (UTR) DERIVED FROM XENOPUS LAEVIS .BETA.-GLOBIN GENE (HBB) AND A 3' UTR DERIVED FROM THE HUMAN .ALPHA.-GLOBIN GENE (HBA1), AND TERMINATED BY A 3' POLYADENYLATION (POLYA) TAIL
RNA (RECOMBINANT 5'-(M7G-(5'->5')-PPP-GM)-CAPPED HUMAN IMMUNOGLOBULIN IGE .EPSILON.-CHAIN SIGNAL PEPTIDE PLUS SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN B.1.1.529.4 AND B.1.1.529.5 VARIANT RECEPTOR-BINDING DOMAIN PLUS 5'-AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGER ABO1020), INNER SALT
VECILMERAN
VECILMERAN [INN]
CAS登记号2854349-87-2
物质唯一标识(Unique Ingredient Identifier)28PLX9696B
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System